Ten differentially expressed circulating inflammatory biomarkers (CD40L, HGF, IL-1β, IL-10, IL-16, IL-2, IL-5, IL-2Rα, CCL20, and MMP1) between AIS patients and healthy controls were screened from a broad panel of 65 cytokines [5]. This evidence concerns the gene IL16 and androgen insensitivity syndrome.